Live Breaking News & Updates on Reshma kewalramani

Stay updated with breaking news from Reshma kewalramani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy?

We recently compiled a list of the 11 Best Feminist Stocks To Invest In. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other feminist stocks. With the passage of time, the role of women in the modern day workplace has slowly started to grow. […] ....

Boston , Massachusetts , United-states , Reshma-kewalramani , Harding-loevner , Vertex-pharmaceuticals , Vertex-pharmaceuticals-incorporated , Pharmaceuticals-incorporated , Sector-perform , Feminist-stocks-to-invest-into ,

Washington Trust Bank Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Washington Trust Bank lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 36,061 shares of the pharmaceutical company’s stock after selling 2,315 shares during the quarter. Vertex Pharmaceuticals comprises approximately 1.3% of […] ....

Washington , United-states , Canada , Piper-sandler , Brucei-sachs , Reshma-kewalramani , Washington-trust-bank , Vertex-pharmaceuticals , Blair-william-co , Quarter-for-vertex-pharmaceuticals , Royal-bank , Vertex-pharmaceuticals-company-profile

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....

Brucei-sachs , Reshma-kewalramani , Piper-sandler , News-ratings-for-vertex-pharmaceuticals-daily , Insider-transactions-at-vertex-pharmaceuticals , Canaccord-genuity-group , Securities-exchange-commission , Vertex-pharmaceuticals-profile , Wolfe-research , Bellevue-group , Telos-capital-management-inc , Quarter-for-vertex-pharmaceuticals

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....

Reshma-kewalramani , Brucei-sachs , Piper-sandler , Canaccord-genuity-group , Telos-capital-management-inc , Cantor-fitzgerald , Quarter-for-vertex-pharmaceuticals , Sherbrooke-park-advisers , Vertex-pharmaceuticals-stock , Insider-transactions-at-vertex-pharmaceuticals , Vertex-pharmaceuticals , Securities-exchange-commission